Literature DB >> 20537810

A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit.

John R Hughes1, Laura J Solomon, Amy E Livingston, Peter W Callas, Erica N Peters.   

Abstract

Most smoking cessation programs advise abrupt rather than gradual cessation. We conducted a randomized, controlled trial of gradual cessation (n=297) vs. abrupt cessation (n=299) vs. minimal treatment (n=150) among smokers who wanted to quit now and preferred to quit gradually. Participants were recruited via newspaper and radio advertisements. The gradual and abrupt conditions received five phone calls (total=90 min) and the minimal treatment condition received two calls (25 min total). The gradual condition received nicotine lozenge (via mail) to reduce smoking prior to their quit date. After the quit day, all participants received lozenge. The primary outcome was prolonged abstinence from 2 weeks post-quit day through 6 months. Prior to the quit day, the gradual condition decreased cigarettes/day by 54%, whereas the other two conditions decreased by 1% and 5%. Prolonged abstinence rates (CO<10 ppm) did not differ among gradual, abrupt and minimal treatment conditions (4%, 7% and 5%), nor did 7-day point prevalence rates (7%, 11% and 11%). Fewer smokers in the gradual condition (48%) made a quit attempt than in the abrupt (64%) or minimal (60%) conditions (p<.001). In the gradual condition, every week delay to the quit date increased the probability of lapsing by 19% (p<.001). We conclude that among smokers who want to stop gradually in the near future, gradual cessation with nicotine pre-treatment does not produce higher quit rates than abrupt cessation. One liability of gradual reduction may be that it allows smokers to delay their quit date. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537810      PMCID: PMC2930079          DOI: 10.1016/j.drugalcdep.2010.04.007

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  45 in total

1.  Relapse situations and self-efficacy: an integrative model.

Authors:  W F Velicer; C C Diclemente; J S Rossi; J O Prochaska
Journal:  Addict Behav       Date:  1990       Impact factor: 3.913

2.  Format and quitting instructions as factors influencing the impact of a self-administered quit smoking program.

Authors:  K M Cummings; S L Emont; C Jaén; R Sciandra
Journal:  Health Educ Q       Date:  1988

3.  An evaluation of a multicomponent treatment program involving scheduled smoking and relapse prevention procedures: initial findings.

Authors:  P M Cinciripini; L G Lapitsky; A Wallfisch; R Mace; E Nezami; H Van Vunakis
Journal:  Addict Behav       Date:  1994 Jan-Feb       Impact factor: 3.913

4.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

5.  Smoking cessation--gradual or sudden stopping?

Authors:  V Günther; S Gritsch; U Meise
Journal:  Drug Alcohol Depend       Date:  1992-02       Impact factor: 4.492

Review 6.  Nicotine replacement therapy for smoking cessation.

Authors:  C Silagy; T Lancaster; L Stead; D Mant; G Fowler
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence.

Authors:  Saul Shiffman; Andrew Waters; Mary Hickcox
Journal:  Nicotine Tob Res       Date:  2004-04       Impact factor: 4.244

Review 8.  An analysis of the effectiveness of interventions intended to help people stop smoking.

Authors:  M Law; J L Tang
Journal:  Arch Intern Med       Date:  1995-10-09

9.  The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal?

Authors:  P M Cinciripini; L Lapitsky; S Seay; A Wallfisch; K Kitchens; H Van Vunakis
Journal:  J Consult Clin Psychol       Date:  1995-06

10.  Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program.

Authors:  N Herrera; R Franco; L Herrera; A Partidas; R Rolando; K O Fagerström
Journal:  Chest       Date:  1995-08       Impact factor: 9.410

View more
  35 in total

Review 1.  Pharmacological interventions for the treatment of smokeless tobacco use.

Authors:  Jon O Ebbert; Karl Fagerstrom
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

2.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

Review 3.  Pharmacologic agents for tobacco dependence treatment: 2011 update.

Authors:  J Taylor Hays; David D McFadden; Jon O Ebbert
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

4.  Is delaying a quit attempt associated with less success?

Authors:  John R Hughes; Peter W Callas
Journal:  Nicotine Tob Res       Date:  2011-09-08       Impact factor: 4.244

5.  Abrupt versus gradual smoking cessation with pre-cessation nicotine replacement therapy for cigarette smokers motivated to quit.

Authors:  Elias M Klemperer; Karl O Fagerstrom; John R Hughes
Journal:  Ann Transl Med       Date:  2016-10

Review 6.  Managing smoking cessation.

Authors:  Robert D Reid; Gillian Pritchard; Kathryn Walker; Debbie Aitken; Kerri-Anne Mullen; Andrew L Pipe
Journal:  CMAJ       Date:  2016-10-03       Impact factor: 8.262

7.  Efficacy of a Texting Program to Promote Cessation Among Pregnant Smokers: A Randomized Control Trial.

Authors:  Kathryn I Pollak; Pauline Lyna; Xiaomei Gao; Devon Noonan; Santiago Bejarano Hernandez; Sonia Subudhi; Geeta K Swamy; Laura J Fish
Journal:  Nicotine Tob Res       Date:  2020-06-12       Impact factor: 4.244

8.  An Experimental Feasibility Study of a Hybrid Telephone Counseling/Text Messaging Intervention for Post-Discharge Cessation Support Among Hospitalized Smokers in Brazil.

Authors:  Erica Cruvinel; Kimber P Richter; Fernando Colugnati; Telmo Mota Ronzani
Journal:  Nicotine Tob Res       Date:  2019-11-19       Impact factor: 4.244

9.  Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study.

Authors:  Kevin P Hill; Lindsay H Toto; Scott E Lukas; Roger D Weiss; George H Trksak; John M Rodolico; Shelly F Greenfield
Journal:  Am J Addict       Date:  2013 May-Jun

10.  Integrating a Behavioural Sleep Intervention into Smoking Cessation Treatment for Smokers with Insomnia: A Randomised Pilot Study.

Authors:  Lisa M Fucito; Nancy S Redeker; Samuel A Ball; Benjamin A Toll; Jolomi T Ikomi; Kathleen M Carroll
Journal:  J Smok Cessat       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.